Skip to content
10-Q

Quarterly Report

MERRIMACK PHARMACEUTICALS INC

0000950170-23-058273

← back to feed
Filed
Nov 2, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Oct 31, 2023 14.32M sh
Shares Diluted Q3 2023 · Sep 30, 2023 14.32M sh
Shares Diluted Q3 2023 · Sep 30, 2023 14.29M sh
Shares Diluted Q3 2023 · Sep 30, 2022 13.41M sh
Shares Diluted Q3 2023 · Sep 30, 2022 13.41M sh
Operating Cash Flow Q3 2023 · Sep 30, 2023 −$1.23M
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$1.56M
Short Term Investments Q3 2023 · Sep 30, 2023 $12.82M
Short Term Investments Q3 2023 · Dec 31, 2022 $0
Cash And Equivalents Q3 2023 · Sep 30, 2023 $6.08M
Cash And Equivalents Q3 2023 · Dec 31, 2022 $19.44M
Stockholders Equity Q3 2023 · Sep 30, 2023 $18.81M
Stockholders Equity Q3 2023 · Jun 30, 2023 $19.04M
Stockholders Equity Q3 2023 · Mar 31, 2023 $19.17M
Stockholders Equity Q3 2023 · Dec 31, 2022 $19.25M
Stockholders Equity Q3 2023 · Sep 30, 2022 $13.19M
Stockholders Equity Q3 2023 · Jun 30, 2022 $13.61M
Stockholders Equity Q3 2023 · Mar 31, 2022 $14.08M
Stockholders Equity Q3 2023 · Dec 31, 2021 $14.19M
Current Liabilities Q3 2023 · Sep 30, 2023 $493K
Current Liabilities Q3 2023 · Dec 31, 2022 $589K
Total Liabilities Q3 2023 · Sep 30, 2023 $493K
Total Liabilities Q3 2023 · Dec 31, 2022 $589K
Current Assets Q3 2023 · Sep 30, 2023 $19.29M
Current Assets Q3 2023 · Dec 31, 2022 $19.83M
Total Assets Q3 2023 · Sep 30, 2023 $19.3M
Total Assets Q3 2023 · Dec 31, 2022 $19.84M
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.02
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.07
Eps Diluted Q3 2023 · Sep 30, 2022 −$0.03
Eps Diluted Q3 2023 · Sep 30, 2022 −$0.08
Eps Basic Q3 2023 · Sep 30, 2023 −$0.02
Eps Basic Q3 2023 · Sep 30, 2023 −$0.07
Eps Basic Q3 2023 · Sep 30, 2022 −$0.03
Eps Basic Q3 2023 · Sep 30, 2022 −$0.08
Operating Income Q3 2023 · Sep 30, 2023 −$531K
Operating Income Q3 2023 · Sep 30, 2023 −$1.55M
Operating Income Q3 2023 · Sep 30, 2022 −$504K
Operating Income Q3 2023 · Sep 30, 2022 −$1.12M